By Professor Jason Grebely

Conference Posters

Litwin AH; Drolet M; Nwankwo C; Torrens M; Kastelic A; Walcher S; Somaini L; Mulvihill E; Ertl J; Grebely J, 2019, 'Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study', Vol. 26, pp. 1094 - 1104, http://dx.doi.org/10.1111/jvh.13119

Kwon A; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham E; Estes C; Razavi H; Gray RT, 2018, 'Australia on track to achieve WHO elimination targets following rapid initial DAA treatment uptake', presented at International Liver Congress (European Association for the Study of the Liver (EASL 2018)), 11 April 2018 - 15 April 2018

Cunningham EB; Hajarizadeh B; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Bretana NA; Dolan K; Lloyd AR; Grebely J, 2018, 'Ongoing incident hepatitic c virus infection among people with a history of injecting drug use in an Australian prison setting', Vol. 1, pp. 278 - 280, http://dx.doi.org/10.1093/JCAG/GWY008.162

, 2015, 'P080: Characterizing hepatitis C virus transmission dynamics using molecular phylogenetic‐based methods', Vol. 22, pp. 60 - 60, http://dx.doi.org/10.1111/jvh.76_12425

Back to profile page